Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of patients with biliary tract cancer, especially with intrahepatic cholangiocarcinoma

Background/Aims Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is a standard diagnostic method for biliary tract cancer (BTC), and samples obtained in this manner may be used for comprehensive genomic profiling (CGP). This study evaluated the utility of EUS-TA for CGP in a clinical setting...

Full description

Saved in:
Bibliographic Details
Main Authors: Takafumi Yanaidani (Author), Kazuo Hara (Author), Nozomi Okuno (Author), Shin Haba (Author), Takamichi Kuwahara (Author), Yasuhiro Kuraishi (Author), Nobumasa Mizuno (Author), Sho Ishikawa (Author), Masanori Yamada (Author), Tsukasa Yasuda (Author)
Format: Book
Published: Korean Society of Gastrointestinal Endoscopy, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a7c1c7d395c846c5b5ff89a0109f7bb3
042 |a dc 
100 1 0 |a Takafumi Yanaidani  |e author 
700 1 0 |a Kazuo Hara  |e author 
700 1 0 |a Nozomi Okuno  |e author 
700 1 0 |a Shin Haba  |e author 
700 1 0 |a Takamichi Kuwahara  |e author 
700 1 0 |a Yasuhiro Kuraishi  |e author 
700 1 0 |a Nobumasa Mizuno  |e author 
700 1 0 |a Sho Ishikawa  |e author 
700 1 0 |a Masanori Yamada  |e author 
700 1 0 |a Tsukasa Yasuda  |e author 
245 0 0 |a Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of patients with biliary tract cancer, especially with intrahepatic cholangiocarcinoma 
260 |b Korean Society of Gastrointestinal Endoscopy,   |c 2024-05-01T00:00:00Z. 
500 |a 2234-2400 
500 |a 2234-2443 
500 |a 10.5946/ce.2023.139 
520 |a Background/Aims Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is a standard diagnostic method for biliary tract cancer (BTC), and samples obtained in this manner may be used for comprehensive genomic profiling (CGP). This study evaluated the utility of EUS-TA for CGP in a clinical setting and determined the factors associated with the adequacy of CGP in patients with BTC. Methods CGP was attempted for 105 samples from 94 patients with BTC at the Aichi Cancer Center, Japan, from October 2019 to April 2022. Results Overall, 77.1% (81/105) of the samples were adequate for CGP. For 22-G or 19-G fine-needle biopsy (FNB), the sample adequacy was 85.7% (36/42), which was similar to that of surgical specimens (94%, p=0.45). Univariate analysis revealed that 22-G or larger FNB needle usage (86%, p=0.003), the target primary lesions (88%, p=0.015), a target size ≥30 mm (100%, p=0.0013), and number of punctures (90%, p=0.016) were significantly positively associated with CGP sample adequacy. Conclusions EUS-TA is useful for CGP tissue sampling in patients with BTC. In particular, the use of 22-G or larger FNB needles may allow for specimen adequacy comparable to that of surgical specimens. 
546 |a EN 
690 |a biliary tract neoplasm 
690 |a endoscopic ultrasound-guided fine needle aspiration 
690 |a fine needle biopsy 
690 |a genetic profile 
690 |a precision medicine 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Diseases of the digestive system. Gastroenterology 
690 |a RC799-869 
655 7 |a article  |2 local 
786 0 |n Clinical Endoscopy, Vol 57, Iss 3, Pp 384-392 (2024) 
787 0 |n http://www.e-ce.org/upload/pdf/ce-2023-139.pdf 
787 0 |n https://doaj.org/toc/2234-2400 
787 0 |n https://doaj.org/toc/2234-2443 
856 4 1 |u https://doaj.org/article/a7c1c7d395c846c5b5ff89a0109f7bb3  |z Connect to this object online.